Based on these analyses, ESR1, CYP1A2, and AURKA were identified as key genes, and their significant roles in HCC progression and prognosis were validated through immune infiltration, drug sensitivity analysis, and survival curves [86]. Here, CYP1A2 is linked to hepatocellular carcinoma.